Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

Children's Access to Vital Medication

Lee O'Doherty-Bushnell

Lee O'Doherty-Bushnell

Tuesday 18 Jul 2023

One particularly poignant example of the consequences faced by vulnerable populations is the case of children who require cannabis-based medicines for the treatment of epilepsy. Epilepsy is a neurological condition characterized by recurring seizures, and for some children, traditional medications may not effectively control their seizures. In such cases, cannabis-based medicines have shown promise in reducing seizure frequency and improving quality of life.

However, the current healthcare system places a significant financial burden on families seeking cannabis-based treatments for their children. The NHS does not routinely prescribe these medications, forcing families to turn to private healthcare options to access the necessary treatment. The costs associated with private consultations, prescriptions, and ongoing medication expenses can quickly accumulate, placing an immense strain on families, particularly those who are already financially vulnerable.

This lack of affordable access to vital medication raises significant ethical concerns. Children with epilepsy and their families are faced with a difficult choice: either bear the financial burden of private healthcare or forgo potentially life-changing treatments altogether. This dilemma not only jeopardizes the well-being and quality of life of these children but also underscores a disregard for the needs and rights of vulnerable populations within the healthcare system.

It is imperative that equitable access to vital medications be ensured for all children who could benefit from them. The financial barriers that prevent children with epilepsy from accessing cannabis-based medicines must be addressed through policy changes and increased support. This includes incorporating these medications into the NHS formulary, making them available free of charge or at an affordable cost for those who need them.

Furthermore, efforts should be made to expand research and evidence surrounding the use of cannabis-based medicines for epilepsy treatment. This would help establish a clearer understanding of their efficacy and safety profile, enabling informed decision-making by healthcare providers and policymakers.

By ensuring affordable access to vital medication for children with epilepsy, we can uphold the principles of equitable healthcare and prioritize the well-being and quality of life of the most vulnerable members of society. Additionally, this case serves as a reminder of the broader challenges faced by individuals who find themselves trapped in the financial burden of private healthcare due to the strain on the NHS.

In the next e will address the need for comprehensive solutions to alleviate the financial burden on vulnerable populations and promote equitable access to healthcare for all individuals in the United Kingdom.

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!